For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Prometheus Laboratories Inc.

USPTO Granted Patents = 22

% Expired Patents = 13.6

CIPO Patents = 2

EPO Patents = 3

Trademarks = 21

Forward Citations = 197

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Sharat Singh (7 out of 100 patents)

Bruce P Neri (4 out of 40 patents)

Thierry Dervieux (3 out of 11 patents)

4. Anjali Jain (3 out of 7 patents)

5. Venkateswarlu Kondragunta (3 out of 6 patents)

6. Esther H Oh (3 out of 3 patents)

7. Stephan R Targan (2 out of 53 patents)

8. Nicholas Hoe (2 out of 3 patents)

9. Steve Lockton (2 out of 3 patents)

10. Scott Hauenstein (2 out of 6 patents)

11. Linda Ohrmund (2 out of 10 patents)

12. Michael Hale (2 out of 10 patents)

13. Jeanne Harvey (2 out of 10 patents)

14. Augusto Lois (2 out of 5 patents)

15. Paul Barstad (2 out of 2 patents)

22 patents: Sort by Forward Citations

1. 12485171 - Methods of disease activity profiling for personalized therapy management (2025-12-02),

2. 12422432 - Methods for assessing mucosal healing in inflammatory bowel disease patients (2025-09-23),

3. 11846642 - Indirect homogeneous mobility shift assays for the detection of biologics in patient samples (2023-12-19),

4. 11796541 - Methods for assessing mucosal healing in ulcerative colitis disease patients (2023-10-24),

5. 11435347 - Methods for prediction of anti-TNF α drug levels and autoantibody formation (2022-09-06),

6. 11160863 - Methods of disease activity profiling for personalized therapy management (2021-11-02),

7. 8163499 - Drug selection for breast cancer therapy using antibody-based arrays (2012-04-24),

8. 8114616 - Methods for diagnosing irritable bowel syndrome (2012-02-14),

9. 7943328 - Method and system for assisting in diagnosing irritable bowel syndrome (2011-05-17),

10. 7908091 - Methods of predicting and monitoring tyrosine kinase inhibitor therapy (2011-03-15),

11. 7873479 - Methods of diagnosing inflammatory bowel disease (2011-01-18),

12. 7759079 - Methods of diagnosing inflammatory bowel disease (2010-07-20),

13. 7695908 - Methods for predicting methotrexate polyglutamate levels using pharmacogenetics (2010-04-13),

14. 7670764 - Methods of diagnosing tissue fibrosis (2010-03-02),

15. 7582282 - Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics (2009-09-01),

Prometheus Laboratories Inc. is a leading clinical diagnostics and pharmaceutical company. With a focus on precision medicine, Prometheus develops and commercializes innovative tests and therapeutics to improve patient outcomes. We offer a comprehensive portfolio of diagnostics in the fields of gastroenterology, oncology, and autoimmune diseases. Our mission is to provide physicians and patients with reliable tools and personalized solutions for better healthcare decisions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

22 Patents

#273 in San Diego, CA

#3,581 in California

#15,008 in US

#28,704 in the World

San Diego, CA, United States of America

Prometheus Laboratories Inc.

Forward Citations = 197

36 inventors:

Sharat Singh (7 out of 100 patents)

Bruce P Neri (4 out of 40 patents)

Thierry Dervieux (3 out of 11 patents)

4. Anjali Jain (3 out of 7 patents)

5. Venkateswarlu Kondragunta (3 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…